nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorphenamine—SLC22A2—Organic cation transport—SLC22A4—Crohn's disease	0.068	0.0775	CbGpPWpGaD
Chlorphenamine—SLC22A2—Organic cation transport—SLC22A5—Crohn's disease	0.068	0.0775	CbGpPWpGaD
Chlorphenamine—SLC22A1—Organic cation transport—SLC22A5—Crohn's disease	0.0634	0.0722	CbGpPWpGaD
Chlorphenamine—SLC22A1—Organic cation transport—SLC22A4—Crohn's disease	0.0634	0.0722	CbGpPWpGaD
Chlorphenamine—Mepyramine—SLC22A4—Crohn's disease	0.0563	0.461	CrCbGaD
Chlorphenamine—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0461	0.0525	CbGpPWpGaD
Chlorphenamine—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0461	0.0525	CbGpPWpGaD
Chlorphenamine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.043	0.049	CbGpPWpGaD
Chlorphenamine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.043	0.049	CbGpPWpGaD
Chlorphenamine—Mepyramine—SLC22A5—Crohn's disease	0.0423	0.347	CrCbGaD
Chlorphenamine—SLC6A3—Parkinsons Disease Pathway—LRRK2—Crohn's disease	0.0209	0.0239	CbGpPWpGaD
Chlorphenamine—Diphenhydramine—SLC22A5—Crohn's disease	0.0154	0.127	CrCbGaD
Chlorphenamine—SLC6A4—Serotonin Transporter Activity—IL1B—Crohn's disease	0.0139	0.0158	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.0115	0.0131	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.0115	0.0131	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—CREM—Crohn's disease	0.0107	0.0122	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.0102	0.0116	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.0102	0.0116	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00924	0.0105	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00924	0.0105	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—CREM—Crohn's disease	0.00875	0.00997	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00861	0.00981	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00861	0.00981	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.00714	0.00813	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.00633	0.0072	CbGpPWpGaD
Chlorphenamine—HRH1—G alpha (q) signalling events—MLN—Crohn's disease	0.00609	0.00694	CbGpPWpGaD
Chlorphenamine—SLC6A4—Monoamine Transport—IL1B—Crohn's disease	0.00591	0.00673	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.00576	0.00656	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.00545	0.0062	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.00537	0.00611	CbGpPWpGaD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00521	0.00593	CbGpPWpGaD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00521	0.00593	CbGpPWpGaD
Chlorphenamine—SLC6A2—Monoamine Transport—IL1B—Crohn's disease	0.00508	0.00579	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00497	0.00566	CbGpPWpGaD
Chlorphenamine—HRH1—IL-4 Signaling Pathway—SOCS1—Crohn's disease	0.00496	0.00565	CbGpPWpGaD
Chlorphenamine—Clomipramine—ALB—Crohn's disease	0.00474	0.0388	CrCbGaD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00462	0.00526	CbGpPWpGaD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00462	0.00526	CbGpPWpGaD
Chlorphenamine—SLC6A3—Monoamine Transport—IL1B—Crohn's disease	0.0045	0.00513	CbGpPWpGaD
Chlorphenamine—SLC6A4—Monoamine Transport—TNF—Crohn's disease	0.00429	0.00488	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00426	0.00485	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metapathway biotransformation—GPX4—Crohn's disease	0.00421	0.0048	CbGpPWpGaD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.0042	0.00478	CbGpPWpGaD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.0042	0.00478	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00403	0.00459	CbGpPWpGaD
Chlorphenamine—SLC6A3—Dopaminergic Neurogenesis—STAT3—Crohn's disease	0.00397	0.00453	CbGpPWpGaD
Chlorphenamine—HRH1—G alpha (q) signalling events—GPR65—Crohn's disease	0.00392	0.00447	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00391	0.00446	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00391	0.00446	CbGpPWpGaD
Chlorphenamine—SLC6A2—Monoamine Transport—TNF—Crohn's disease	0.00369	0.0042	CbGpPWpGaD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00367	0.00418	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.00351	0.004	CbGpPWpGaD
Chlorphenamine—SLC6A3—Monoamine Transport—TNF—Crohn's disease	0.00327	0.00372	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00326	0.00372	CbGpPWpGaD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00325	0.0037	CbGpPWpGaD
Chlorphenamine—Chlorpromazine—ALB—Crohn's disease	0.00325	0.0266	CrCbGaD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.00324	0.0037	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—ACKR2—Crohn's disease	0.00324	0.00369	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.00317	0.00361	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—MLN—Crohn's disease	0.00307	0.0035	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metapathway biotransformation—GPX4—Crohn's disease	0.00304	0.00347	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00303	0.00346	CbGpPWpGaD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00296	0.00337	CbGpPWpGaD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.00287	0.00327	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.0028	0.00318	CbGpPWpGaD
Chlorphenamine—HRH1—IL-4 Signaling Pathway—TYK2—Crohn's disease	0.0028	0.00318	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00276	0.00314	CbGpPWpGaD
Chlorphenamine—HRH1—IL-4 Signaling Pathway—JAK2—Crohn's disease	0.00267	0.00304	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00265	0.00302	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00265	0.00302	CbGpPWpGaD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.00262	0.00298	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.0026	0.00296	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.00244	0.00278	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00235	0.00267	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00235	0.00267	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.00216	0.00247	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00216	0.00246	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00213	0.00243	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00213	0.00243	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CCR9—Crohn's disease	0.00213	0.00243	CbGpPWpGaD
Chlorphenamine—HRH1—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.00203	0.00231	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00199	0.00227	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00199	0.00227	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—GPR65—Crohn's disease	0.00198	0.00225	CbGpPWpGaD
Chlorphenamine—HRH1—IL-4 Signaling Pathway—STAT3—Crohn's disease	0.00196	0.00223	CbGpPWpGaD
Chlorphenamine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.0019	0.00217	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00187	0.00212	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00185	0.00211	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00181	0.00207	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—MLN—Crohn's disease	0.00174	0.00198	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.00173	0.00198	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.00166	0.0019	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—ACKR2—Crohn's disease	0.00166	0.00189	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00165	0.00188	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00165	0.00188	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00163	0.00186	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—MLN—Crohn's disease	0.00158	0.0018	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.0015	0.00171	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00146	0.00166	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.00142	0.00161	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CCR6—Crohn's disease	0.00141	0.00161	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.0014	0.0016	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00133	0.00151	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—PTGER4—Crohn's disease	0.00124	0.00141	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00124	0.00141	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.00121	0.00138	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—CCR9—Crohn's disease	0.0012	0.00137	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	0.00118	0.00134	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—PLA2G4F—Crohn's disease	0.00118	0.00134	CbGpPWpGaD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.00117	0.00133	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—GPR65—Crohn's disease	0.00112	0.00127	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—PLA2G4F—Crohn's disease	0.0011	0.00125	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CCR9—Crohn's disease	0.00109	0.00124	CbGpPWpGaD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.00103	0.00118	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—GPR65—Crohn's disease	0.00102	0.00116	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—MTMR3—Crohn's disease	0.001	0.00114	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—MTMR3—Crohn's disease	0.001	0.00114	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—ACKR2—Crohn's disease	0.000982	0.00112	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000974	0.00111	CbGpPWpGaD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000942	0.00107	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—MTMR3—Crohn's disease	0.000932	0.00106	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—MLN—Crohn's disease	0.000931	0.00106	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000926	0.00105	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000883	0.00101	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000878	0.001	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—TAGAP—Crohn's disease	0.000852	0.00097	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	0.000851	0.000969	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—CCR6—Crohn's disease	0.000797	0.000908	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—IL6—Crohn's disease	0.000796	0.000906	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—FADS1—Crohn's disease	0.00078	0.000888	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—FADS1—Crohn's disease	0.000779	0.000887	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—RSPO3—Crohn's disease	0.000744	0.000848	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GPX4—Crohn's disease	0.00073	0.000832	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GPX4—Crohn's disease	0.000729	0.00083	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—FADS1—Crohn's disease	0.000726	0.000827	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CCR6—Crohn's disease	0.000724	0.000824	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—MTMR3—Crohn's disease	0.000724	0.000824	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—SEL1L—Crohn's disease	0.000706	0.000804	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GCKR—Crohn's disease	0.000705	0.000803	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GCKR—Crohn's disease	0.000704	0.000802	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000702	0.000799	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—GPX4—Crohn's disease	0.00068	0.000774	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—GCKR—Crohn's disease	0.000656	0.000748	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CCR9—Crohn's disease	0.000645	0.000735	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—PTGER4—Crohn's disease	0.000637	0.000726	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	0.000605	0.000689	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—GPR65—Crohn's disease	0.0006	0.000683	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—IL3—Crohn's disease	0.000598	0.000681	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000597	0.00068	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000594	0.000676	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000578	0.000658	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—FADS1—Crohn's disease	0.000564	0.000642	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—IL3—Crohn's disease	0.000543	0.000618	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GPX4—Crohn's disease	0.000528	0.000601	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000526	0.000599	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000525	0.000598	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—MTMR3—Crohn's disease	0.000515	0.000586	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GCKR—Crohn's disease	0.00051	0.000581	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000479	0.000545	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CXCL8—Crohn's disease	0.000455	0.000518	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000453	0.000516	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000446	0.000508	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CCR6—Crohn's disease	0.000428	0.000487	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000419	0.000477	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—FADS1—Crohn's disease	0.000401	0.000457	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	0.000396	0.000451	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—RBX1—Crohn's disease	0.000387	0.00044	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—IL2RA—Crohn's disease	0.00038	0.000433	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PTGER4—Crohn's disease	0.000376	0.000429	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GPX4—Crohn's disease	0.000375	0.000428	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GCKR—Crohn's disease	0.000363	0.000413	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	0.000339	0.000386	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—MTMR3—Crohn's disease	0.000336	0.000383	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—RIPK2—Crohn's disease	0.000329	0.000374	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—IL3—Crohn's disease	0.000321	0.000365	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	0.00031	0.000353	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	0.000281	0.000321	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—SOCS1—Crohn's disease	0.000281	0.00032	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—TYK2—Crohn's disease	0.000268	0.000305	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—FADS1—Crohn's disease	0.000262	0.000299	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000257	0.000293	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—JAK2—Crohn's disease	0.000256	0.000291	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GPX4—Crohn's disease	0.000245	0.00028	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—SMAD3—Crohn's disease	0.000243	0.000276	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GCKR—Crohn's disease	0.000237	0.00027	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	0.000233	0.000266	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—IL2RA—Crohn's disease	0.000225	0.000256	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—ALB—Crohn's disease	0.000224	0.000256	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—ALB—Crohn's disease	0.000224	0.000255	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—ALB—Crohn's disease	0.000209	0.000238	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—PTGS2—Crohn's disease	0.000196	0.000224	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—PTGS2—Crohn's disease	0.000196	0.000223	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—PTGS2—Crohn's disease	0.000183	0.000208	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—ALB—Crohn's disease	0.000162	0.000185	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—TYK2—Crohn's disease	0.000158	0.00018	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—JAK2—Crohn's disease	0.000151	0.000172	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—PTGS2—Crohn's disease	0.000142	0.000162	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CXCL8—Crohn's disease	0.000138	0.000157	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—IL6—Crohn's disease	0.000131	0.000149	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—ALB—Crohn's disease	0.000115	0.000131	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—STAT3—Crohn's disease	0.000111	0.000126	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—PTGS2—Crohn's disease	0.000101	0.000115	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—IL6—Crohn's disease	7.74e-05	8.82e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—ALB—Crohn's disease	7.54e-05	8.59e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—PTGS2—Crohn's disease	6.6e-05	7.52e-05	CbGpPWpGaD
